NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

doi:10.6004/jnccn.2020.0017

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 Apr 2020

Daly Mary B, Pilarski Robert, Yurgelun Matthew B, Berry Michael P, Buys Saundra S, Dickson Patricia, Domchek Susan M, Elkhanany Ahmed, Friedman Susan, Garber Judy E, Goggins Michael, Hutton Mollie L, Khan Seema, Klein Catherine, Kohlmann Wendy, Kurian Allison W, Laronga Christine, Litton Jennifer K, Mak Julie S, Menendez Carolyn S, Merajver Sofia D, Norquist Barbara S, Offit Kenneth, Pal Tuya, Pederson Holly J, Reiser Gwen, Shannon Kristen Mahoney, Visvanathan Kala, Weitzel Jeffrey N, Wick Myra J, Wisinski Kari B, Dwyer Mary A, Darlow Susan D

Abstract excerpt

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic provide recommendations for genetic testing and counseling for hereditary cancer syndromes, and risk management recommendations for patients who are diagnosed with syndromes associated with an increased risk of these cancers. The NCCN panel meets at least annually to review comments, examine relevant new data, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Genetic Counseling

Share to Genetic Testing

Share to Neoplastic Syndromes, Hereditary

Share to Ovarian Neoplasms

Share to Pancreatic Neoplasms

Share to Penetrance

Source

Open in PubMed

Identifiers

PMID: 32259785
DOI: 10.6004/jnccn.2020.0017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.PMID 32259785Read ↗

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.Semantic proximity Read ↗

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.Semantic proximity Read ↗

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Semantic proximity Read ↗

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.Semantic proximity Read ↗

NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian CancerSemantic proximity Read ↗

The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024).Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.Semantic proximity Read ↗

EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.Semantic proximity Read ↗

SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).Semantic proximity Read ↗

Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.